Influence of food on bioavailability from two controlled-release granules of theophylline. 1989

H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
Department of Pharmaceutical Science, Akita University Hospital, Japan.

The bioavailability and absorption pattern of theophylline from Theolong granule and Theodur-G were studied in five healthy volunteers both in fasting conditions and after taking two different meals. In all the subjects, no dose-dumping effect was observed with a standard- or a fat-rich breakfast on these preparations. Postprandial administration delayed the absorption of theophylline and a fat-rich breakfast significantly reduced the area under the curve (AUC0-26) for both preparations. The mean AUC decreased by 14.0% for the former and 19.7% for the latter when the fat-rich breakfast was administered. Intake of a standard breakfast resulted in a decrease in the AUC0-26 by 10.6% for Theolong granules but there was little effect observed with the Theodur-G granules.

UI MeSH Term Description Entries
D008297 Male Males
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo

Related Publications

H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
February 1987, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
August 1988, International journal of clinical pharmacology, therapy, and toxicology,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
October 1986, The Journal of allergy and clinical immunology,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
October 1987, Clinical pharmacokinetics,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
July 1991, Arzneimittel-Forschung,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
December 2003, Bollettino chimico farmaceutico,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
March 1994, Arzneimittel-Forschung,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
October 1982, Allergy,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
March 1990, Biopharmaceutics & drug disposition,
H Tada, and M Ishikawa, and E Sato, and T Suzuki, and K Unno, and K Miura, and Y Ohmiya, and K Nakai
January 1986, Therapie,
Copied contents to your clipboard!